101 related articles for article (PubMed ID: 22824178)
1. [Analysis of costs and cost-effectiveness of the preferred treatments by GESIDA/National plan for AIDS for initial antiretroviral therapy in 2012].
Martín-Herrero JE; Parrondo-García J; Rodríguez-Alcántara F
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):509-10; author reply 511-2. PubMed ID: 22824178
[No Abstract] [Full Text] [Related]
2. [Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines].
Betegón L; Cotarelo M; Vendrell B
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):508-9; author reply 511-2. PubMed ID: 22819541
[No Abstract] [Full Text] [Related]
3. [Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):283-93. PubMed ID: 22525829
[TBL] [Abstract][Full Text] [Related]
4. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Rivero A; Pérez-Molina JA; Blasco AJ; Arribas JR; Crespo M; Domingo P; Estrada V; Iribarren JA; Knobel H; Lázaro P; López-Aldeguer J; Lozano F; Moreno S; Palacios R; Pineda JA; Pulido F; Rubio R; de la Torre J; Tuset M; Gatell JM
Enferm Infecc Microbiol Clin; 2017 Feb; 35(2):88-99. PubMed ID: 27459919
[TBL] [Abstract][Full Text] [Related]
5. [Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy].
Blasco AJ; Arribas JR; Clotet B; Domingo P; González-García J; López-Bernaldo JC; Llibre JM; Lozano F; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM
Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):721-30. PubMed ID: 22014894
[TBL] [Abstract][Full Text] [Related]
6. Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Berenguer J; Rivero A; Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; Lázaro P; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Tuset M; Gatell JM;
Enferm Infecc Microbiol Clin; 2016; 34(6):361-71. PubMed ID: 26321131
[TBL] [Abstract][Full Text] [Related]
7. Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Blasco AJ; Llibre JM; Berenguer J; González-García J; Knobel H; Lozano F; Podzamczer D; Pulido F; Rivero A; Tuset M; Lázaro P; Gatell JM;
Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):156-65. PubMed ID: 25175171
[TBL] [Abstract][Full Text] [Related]
8. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
[No Abstract] [Full Text] [Related]
9. [Budget impact analysis of antiretroviral therapy. A reflection based on the GESIDA guidelines].
Grupo de trabajo de la Cohorte VACH
Gac Sanit; 2012; 26(6):541-6. PubMed ID: 22498716
[TBL] [Abstract][Full Text] [Related]
10. [Declining costs].
Neumaier J
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
[No Abstract] [Full Text] [Related]
11. [The cost of an HIV patient. Lack of funds for optimal treatment?].
Stoll M; Schulte E; Claes C; Graf von der Schulenburg JM; Schmidt RE
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():72-7. PubMed ID: 11373789
[TBL] [Abstract][Full Text] [Related]
12. Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
Boulle A; Kenyon C; Skordis J; Wood R
S Afr Med J; 2002 Oct; 92(10):811-7. PubMed ID: 12432807
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Wolf E; Rüsenberg R
MMW Fortschr Med; 2015 Jun; 157 Suppl 2():42-5. PubMed ID: 26048120
[No Abstract] [Full Text] [Related]
14. [Costs and cost effectiveness analysis of preferred GESIDA regimens for initial antiretroviral therapy].
Burgos A; de Álvaro C
Enferm Infecc Microbiol Clin; 2012 Mar; 30(3):167-8; author reply 168-9. PubMed ID: 22244991
[No Abstract] [Full Text] [Related]
15. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa.
Tucker T; Slack C
Lancet; 2003 Sep; 362(9388):995. PubMed ID: 14513854
[No Abstract] [Full Text] [Related]
16. [Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013].
Blasco AJ; Llibre JM; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):568-78. PubMed ID: 23969276
[TBL] [Abstract][Full Text] [Related]
17. Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with lopinavir/ritonavir plus lamivudine for initial ART in HIV infected adults.
Gatell Artigas JM; Arribas López JR; Lázaro Y de Mercado P; Blasco Bravo AJ
Enferm Infecc Microbiol Clin; 2016; 34(7):427-30. PubMed ID: 25749416
[TBL] [Abstract][Full Text] [Related]
18. HIV/AIDS. Triple jump.
Bryan J
Health Serv J; 1998 Apr; 108(5602):suppl 4-6. PubMed ID: 10180412
[No Abstract] [Full Text] [Related]
19. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
[TBL] [Abstract][Full Text] [Related]
20. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
